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a b s t r a c t
Alzheimer’s disease (AD) is the most common form of dementia. The cause of AD is closely related to the
accumulation of amyloid beta peptide in the neuritic plaques. The use of animal model systems repre-
sents a good strategy to elucidate the molecular mechanism behind the development of this pathology.
Here we use the Paracentrotus lividus embryo to identify molecules and pathways that can be involved in
the degenerative process. As a first step, we identified the presence of an antigen related to the human
APP, called PlAPP. This antigen, after gastrula stage, is processed producing a polypeptide of about
10 kDa. By immunohistochemistry we localized the PlAPP antigen in some serotonin expressing cells.
Similarly, after 48 or 96 h incubation, a recombinant b-amyloid peptide, rAb42, accumulates around
the intestinal tube and oesophagus. In addition, incubation of sea urchin embryos with two different
solutions rich in oligomers and fibrillar aggregates of rAb42 induce activation of apoptosis as detected
by TUNEL assay. Moreover, we demonstrate that aggregates induce apoptosis by extrinsic pathway acti-
vation, whereas oligomers induce apoptosis both by extrinsic and intrinsic pathway activation. Utilizing
an apoptotic inhibitor, caspases activation was offset and morphological damage rescued. Taken together
all these observations suggest that the sea urchin may be a simple and suitable model to characterize the
mechanism underlining the cytotoxicity of Ab42.
! 2009 Elsevier Inc. All rights reserved.
Introduction
Alzheimer’s disease is a common pathological process affecting
the elderly, causing progressive loss of cognition. The morphologic
evidences are both extracellular amyloid proteinaceous deposits,
called amyloid plaques and intracellular neurofibrillary tangles.
The major constituent of the amyloid plaques is a hydrophobic
peptide, called amyloid beta protein (Ab). Ab is a 39–42 amino acid
peptide deriving frommultiple proteolytic cleavage at the C-termi-
nal position of a large transmembrane protein, the amyloid precur-
sor protein (APP)1 [1–4]. Ab is able to self-assembly and form
ordered fibril aggregates, typically rich of b-sheet structures that re-
sult to be a key point of the neurodegeneration process. Ab, indeed,
can form oligomers, fibrils and larger clumps of aggregates, both
in vivo and in vitro, depending on the environment conditions
[5,6]. More recent studies have suggested that just these Ab interme-
diates and in particular Ab-derived diffusible ligands (ADDLs) are
important in AD pathogenesis stimulating the inflammation process
and neurodegeneration [7,8]. Whether the aggregation of the pep-
tide into amyloid deposits constitutes clearance of a toxic soluble en-
tity or the amyloid plaques themselves are toxic, is still debated.
Several reports sustain the hypothesis that formation of soluble olig-
omers could play a role at the onset of the pathology [9,10]. The
involvement at this stage of the oligomeric species as real cause of
the disease has suggested interesting strategies to achieve prema-
ture diagnosis of the pathology [11,12].
However, the molecular mechanisms that trigger neurodegen-
eration are not yet well known. Different studies have identified
the apoptotic process as the path for Ab cell death. However, also
in this case, the possibility of a correlation between Ab oligomeric
or aggregates forms and specific apoptotic pathways remains
unclear.
APP is a protein conserved during evolution and APP-related
genes has been found also in less evolutes organisms such as Dro-
sophila melanogaster and the worm Caenorhabditis elegans, suggest-
ing that common mechanisms and answer to pathological stimuli
could be conserved [13–15]. To utilize a simple model system able
to mimic at least a few original mechanisms of a disease, open new
possibilities to test therapeutic strategies. Recently, we have em-
ployed the sea urchin to investigate about a different toxicity be-
tween Ab oligomers and aggregates [16]. In this kind of
experiment sea urchin embryos were separately incubated with a
0003-9861/$ - see front matter ! 2009 Elsevier Inc. All rights reserved.
doi:10.1016/j.abb.2008.12.006
* Corresponding author. Fax: +39 0916809548.
E-mail address: di-carlo@ibim.cnr.it (M. Di Carlo).
1 Abbreviations used: AD, Alzheimer’s disease; APP, amyloid precursor protein;
ADDLs, Ab-derived diffusible ligands; ACh, acetylcholine; ThT, thioflavin-T; ABAD, Ab-
binding alcohol dehydrogenase.
Archives of Biochemistry and Biophysics 483 (2009) 120–126
Contents lists available at ScienceDirect
Archives of Biochemistry and Biophysics
journal homepage: www.elsevier .com/ locate /yabbi
Author's personal copy
recombinant Ab42 (rAb42) peptide dissolved under different con-
ditions at pH 7 or pH 3, to obtain small oligomers or large aggre-
gates, respectively [16]. By the percentage of the survived or
morphologically altered embryos it was possible to demonstrate
that small oligomers are more toxic than large aggregates. In line
with this study, another sea urchin species, Sphaerechinus granular-
is was utilized to establish a potential protective role played by
acetylcholine (ACh), and other neurotransmitters such as serotonin
(5HT) and cannabinoids by Ab42 produced damage [17]. With the
idea of utilizing the Paracentrotus lividus sea urchin as a model sys-
tem to study Ab induced toxicity, we have identified a PlAPP anti-
gen localized in same cells corresponding to the sea urchin
primordial nervous system. Furthermore, we report evidence
about activation of cell death pathway both by Ab oligomers and
aggregates, suggesting that the mechanism of the sea urchin cellu-
lar answer to Ab treatment can be compared to the human one. In
turn, addition of anti-apoptotic compounds reverse caspase activa-
tion, sustaining the idea that sea urchin could be employed for fu-
ture therapeutic strategies.
Materials and methods
Protein extraction and Western blotting
Total proteins were prepared by pulsed sonication for 90 s. in
Solubilising buffer (50 mM Tris–HCl pH 8.0, 150 mMNaCl, 0.5% Tri-
ton X-100, 2 mM PMSF, 10 lg/ml protease inhibitor, 1 mMNa3VO4,
1 mM NaF) from embryos at different development stages in ice.
Protein samples (50 lg) were electrophoretically separated using
12% SDS–PAGE gel and transferred onto nitrocellulose filters for
immunoblotting. After blocking in 3% BSA in PBST (137 mM NaCl,
2.7 mM KCl, 8 mM Na2PO4, pH 7.4, 2% Triton X-100), the Western
blot was incubated with human anti-Ab (1:200; Santa Cruz). Pri-
mary antibody was detected using the ECL chemiluminescence
kit (Amersham) according to the manufacturer’s instructions, and
using an anti-rabbit secondary antibody conjugated to horseradish
peroxidase (1:5000) (Amersham).
Immunohistochemistry of endogenous and exogenous APP
Paracentrotus lividus embryos were cultured in sea water (SW)
without or with 1 lM of rAb42 oligomers and aggregates [16] for
48 and 120 h. After washing in SW were fixed in freshly prepared
4% paraformaldehyde in PBS (137 mM NaCl, 2.7 mM KCl, 8 mM
Na2PO4, pH 7.4) for 30 min, and kept at 4 "C. After three washes
in PBS, the slides were incubated with for 1 h with 3% bovine ser-
um albumine/PBS. Then the embryos were incubated with human
anti-Ab (1:200; Santa Cruz), or with anti-serotonin (1:100; SIGMA)
or anti-His (Penta His Alexa fluor conjugate) (1:100; QIAGEN) at
4 "C overnight. After three washes in PBST (PBS, 2% Triton X-100)
the samples treated with anti-Ab were incubated with anti rabbit
TRITC-conjugate secondary antibody (1:300), and the samples
treated with anti-serotonin were incubated with anti-rabbit FITC-
conjugate secondary antibodies (1:300), whereas the samples trea-
ted with anti-His were directly detected. Fluorescent or light field
images were observed with an Axioscop 2 microscope (Zeiss) and
captured with an Axiocam digital camera (Zeiss) interfaced with
a computer.
Preparation and characterization of Ab42 oligomers and fibrillar
aggregates
Isolation and purification of the rAb42 and the preliminary
treatment with TFA have been reported elsewhere [16]. To obtain
small oligomers, the powder of rAb42 was dissolved in 0.01 M
Tris–HCl buffer pH 7.2, while to obtain large fibrillar aggregates,
a solution of rAb42 was dissolved in 0.1 M Na–citrate buffer pH
3.1 and hold at T = 37 "C for 4 days. In the former case the solution
was readily characterized by dynamic light scattering at T = 15 "C
and then frozen in aliquots to be used for different experiments.
In the latter case the solution at acid pH was also characterized
by dynamic light scattering at T = 15 "C after 4 days incubation at
T = 37 "C and then frozen in aliquots to be used for different
experiments.
Thioflavin T staining
Recombinant Ab42 was dissolved at pH 3.1 and pH 7.2 at a con-
centration of 340 lM and incubated at 37 "C. Aliquots immediately
after dissolution (time 0), and after 48 and 96 h of incubation were
taken and stained adding thioflavin-T at a final concentration of
70 lM and applied to microscope slides. The presence of large
fibrillar aggregates with dimensions in the range of micrometers
was visualized with fluorescence optics of an Axioscop 2 micro-
scope (Zeiss, USA). The images were captured using an Axiocam
digital camera interfaced with a computer.
Paracentrotus lividus morphogenetic assays
Eggs from sea urchins (Paracentrotus lividus) were demembra-
nated by fertilization in 2 mM PABA. Approximately 1000 embryos
were added to artificial sea water (ASW) and purified rAb42 was
added in 8-well plates at two cell stages and the embryos were left
to develop. Depending on the experiment, the rAb42 was solved in
water (to obtain a mixture of oligomers and fibrillar aggregates,
ranging between 5 and 100 nm) or in buffer at pH 3.1 or pH 7.2
and utilized at different doses (0.6 or 1.5 lM). Control embryos,
without any treatment or with specific buffer, were also cultured.
The effect on morphogenesis was observed at different times of
development by microscopic inspection using a Axioscop 2 micro-
scope (Zeiss, USA). The effect on morphogenesis was monitored be-
fore to utilize the embryos for any successive assay. For z-VAD-fmk
experiments 30 lM of z-VAD-fmk (PROMEGA) was added together
0.6 lM of rAb42 oligomers before first cleavage and the embryos
were cultured for 48 h. As control untreated or 0.6 lM rAb42 trea-
ted embryos were utilized. All the images were captured using an
Axiocam digital camera interfaced with a computer.
Apoptosis assays
TUNEL assay was performed according to the manufacturer
instructions (PROMEGA). Briefly, embryos after treatment with
1.5 lM of rAb42, both under oligomers or aggregates forms, for
24 h were fixed with 4% paraformaldehyde in PBS for 30 min.,
washed with PBS permeabilized with 0.2% Triton X-100 in PBS
for 5 min, rinsed with PBS, and incubated with TUNEL reaction
mixture (enzyme, nucleotides) in an humidified atmosphere at
37 "C for 1 h. Staining was obtained by using a peroxidase sub-
strate, hydrogen peroxide, and the stable chromogen, diam-
inobenzidine (DAB). Following these incubations, samples were
rinsed three times with PBS and analysed under Zeiss Axioscop 2
microscope.
Caspase assays
Caspase 8, 9, 3 activities in embryos were measured using com-
mercially available luminescent assays (caspase-GloTM!8, !9, !3/7
assay systems, PROMEGA). P. lividus embryos at gastrula stage
were treated with 1.5 lM oligomers or aggregates for 4 h. Un-
treated embryos were utilized as control. Caspase reagent specific
for each kit was added directly to the cells in white 96-well plates
and after mixing, were incubate for 15–30 min before recording
luminescence with wallacVictor2 1420 MULTILABEL COUNTER (Per-
kin-Elmer) apparatus. The caspase activator assay was performed
utilizing 20 lM vinblastine (SIGMA) and the caspase inhibitor as-
say was performed utilizing 50 lM z-VAD-fmk (PROMEGA). Cas-
pase !8, !9, !3 activity are expressed as a relative percentage of
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untreated samples as 100%. ASW was utilized as blank control. The
experiment was repeated three times and performed in triplicate.
The results are presented as means ± SD.
Results
A PlAPP-related antigen is present and processed during sea urchin
development
The sea urchin larval nervous system consists in an array of
neurons that control swimming and feeding and there begins to
be present a more defined organization at late gastrula [18]. As a
first approach to validate the sea urchin embryo as a model system
in the study of Ab-induced toxicity we planned to identify the pres-
ence of an antigen related to human APP. To investigate about the
presence and expression of a PlAPP-related protein during sea
urchin development, we carried out a Western blot analysis on
protein extracts from embryos at gastrula stage and pluteus larvae
at 48, 120 and 288 h of development.
After extraction, proteins were electrophoresed by SDS–PAGE
and the corresponding immunoblot was incubated with an anti-
body against human APP. As shown in Fig. 1, a band of about
60 kDa is detectable in all the samples. Further, a band of about
10 kDa is present only in the extracts from 48 (pluteus stage),
120 and 288 h embryos. This result suggests that, after gastrula
stage, a portion of the sea urchin PlAPP related protein is proteolit-
ically cleaved producing a peptide, as occurs in higher organisms.
Moreover, to confirm the existence of the gene encoding for
PlAPP, we cloned and sequenced a full-length cDNA (Accession
No. FJ476254) by RT-PCR using total RNA from P. lividus blastula
stage embryos.
Localization of the PlAPP-related antigen
Some studies report that sea urchin nervous system is arranged
in several clusters of neurons that urchin primordial nervous sys-
tem is an array of neurons that has been successfully labelled by
anti-serotonin [18]. To localize PlAPP-related antigen, P. lividus em-
bryos were cultured for 48 and 96 h, to permit advanced morpho-
genetic nervous system events to occur. At these developmental
stages the embryos were fixed and incubated both with anti-sero-
tonin and anti-APP (Fig. 2). By immunohistochemistry using anti-
APP we visualized a punctuate staining around the intestinal tube
and oesophagus. When we merged this image on that obtained by
using anti-serotonin, we detected a jellow staining, principally
around the oesophagus, indicating that colocalization is occurred.
Next, we investigated whether the rAb42, by moving through
extracellular spaces, is able to be incorporated and deposited into
the sea urchin embryos. Embryos treated with a mixture of
rAb42 assemblies, ranging from oligomers to large fibrillar aggre-
gates, were fixed at 48 and 96 h of development and analysed by
immunohistochemistry. For this experiment we utilized a lower
rAb42 concentration (0.6 lM) to avoid drastic damages in the em-
bryos. Further, to be sure to detect exclusively the presence of
exogenous rAb42, we utilized anti-His antibodies against the 6-
His tail which is linked to the N-terminus of the recombinant pep-
tide [16]. As shown in Fig. 2 a punctuate staining, comparable to
that obtained for APP and serotonin, is detectable indicating that
rAb42 is able to be internalized into the embryo, and suggesting
that rAb42 probably binds specific molecules.
rAb42 aggregates in fibrillar structures
We have previously demonstrated that rAb42 induces toxicity
in sea urchin embryos and oligomers are more toxic than aggre-
Fig. 1. PlAPP-related antigen is processed after 48 h of development. Same amount
of proteins extracted from P. lividus embryos developed for 24 (24 h), 48 (48 h), 120
(120 h) and 288 (288 h) hours were loaded on a SDS–PAGE and the Western blot
was incubated with anti-APP.
Fig. 2. Localization of PlAPP and esogenous rAb42. P. lividus embryos at 48 and 96 h of development were fixed and localization of PlAPP-related antigen (48 h, APP), (96 h,
APP) and serotonin (48 h SER, 96 h SER) was visualized by immunohistochemistry and utilizing anti-APP and anti-serotonin. The images were merged (48 h, MERGED), (96 h,
MERGED). Two cell stage sea urchin P. lividus embryos were incubated with rAb42 oligomers of different size and left to develop for 48 and 96 h (48 h, rAb42), (96 h, rAb42).
The embryos were fixed and incubated with anti-His. Bar: 100 lm.
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gates [16]. To define a structure-cell death relationship for the Ab-
peptide, we investigated about a possible different effect for small
oligomers and larger aggregates. As already described by dissolving
rFb42 at pH 7.2 and pH 3.1 we are able to obtain different species
(oligomers or fibrillar aggregates) in solution as monitored by sta-
tic and dynamic light scattering [16]. However, rAb42 neutral and
acid solutions were incubated for different times at 37 "C and their
kinetic of aggregation was monitored after staining with thiofla-
vin-T (ThT) (Fig. 3). No visible structures were detectable after
staining of rAb42 neutral solutions even after 4 days of incubation.
In contrast, by monitoring rAb42 acid solutions at different times,
after 48 h larger and larger structures appeared until the formation
of aggregates of dimensions of around 5 lm. In summary, for all
the degenerative assays we utilized the rAb42 neutral solution
soon after their dissolution, and the rAb42 acid solution after four
days incubation.
rAb42 induces apoptosis in sea urchin embryos
Small oligomers or fibrillar aggregates, were employed to inves-
tigate about the possibility that cell death occurs through the
apoptotic mechanism. Paracentrotus lividus embryos at two cells
stage were incubated with the two types of rFb42 solutions (pH
7.2 and pH 3.1), described above, and the embryos were cultured
until the controls arrived to gastrula and pluteus stages. In agree-
ment to our previous results, we obtained a higher percentage of
malformed or dead embryos upon treatment with rFb42 oligomer
forms with respect to the rFb42 aggregate forms (pH 3.1) (data not
shown). The survived embryos of both treatments were fixed and
submitted to TUNEL assay. In contrast to the control embryos,
showing only some stained nuclei probably due to physiological
events, embryos treated with both oligomers and aggregates
rFb42 showed at 24 h of development a fair number of apoptotic
Fig. 3. Staining with ThT of oligomers and fibrillar aggregates. Kinetic of fibrillar aggregates formation of rAb42 dissolved at pH 7.2 and pH 3.1. Staining with ThT at different
times of incubation at T = 37 "C. Fluorescence images of representative areas of the observation field, immediately after dissolution (time 0) and after 48 (48 h) and 96 h (96 h)
of incubation at T = 37 "C. A particular of aggregates at 96 h in shown in the inset. Bar: 20 lm.
Fig. 4. Oligomers and aggregates activate apoptosis. Sea urchin embryos at 24 (24 h) and 48 (48 h) of development untreated (A and D) or treated with oligomers (B, E and F)
or fibrillar aggregates (C, G and H), were fixed and submitted to TUNEL assay. Bar: 50 lm.
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nuclei (Fig. 4B and C), whereas at 48 of development almost all the
nuclei of the survived embryos were stained. Difference in number
of stained nuclei was observed between oligomers (Fig. 4E and F)
and aggregates treated embryos (Fig. 4G and H), indicating that
oligomers have more severe effects than aggregates.
rAb42 induces caspase-mediated apoptosis
Ab induced apoptosis generally occurs through caspase depen-
dent pathways even if caspase independent pathways have also
been described [19,20]. In sea urchin embryos apoptosis is never
found during cleavage stages. It begins to appear between early
blastula and late gastrula stages [21]. On the basis of this knowl-
edge we incubated Paracentrotus lividus at early gastrula stage with
the two types of rFb42 solutions (pH 7.2 and pH 3.1) and the em-
bryos were cultured for 4 h.
Moreover, we investigate about the possibility that different
apoptotic pathways, extrinsic or intrinsic, could be activated by
the different rAb42 aggregation forms. For this aim P. lividus em-
bryos treated with oligomers and aggregates were submitted to
caspase 8, 9 and 3 assays. A caspase activator and a caspase inhib-
itor z-VAD-fmk were employed as controls. Embryos treated with
aggregates showed activation of caspase 8 (Fig. 5A) and no activa-
tion of caspase 9 with respect to the control (Fig. 5B), whereas em-
bryos treated with oligomers showed both activation of caspase 8
(Fig. 5A) and of caspase 9 (Fig. 5B). P lividus embryos treated as de-
scribed above were employed for the caspase 3 assay and, as ex-
pected, caspase 3 activity was detected for both treatments
(Fig. 5C). Moreover, we treated P. lividus embryos both with
rAb42 oligomers and zVADfmk and after 48 h of development a
rescue of the morphology was detected (Fig. 6C), with respect to
the oligomers treated embryo (Fig. 6B), indicating that the drug
has antagonised the amyloid effect.
Discussion
Reliable animal models are required to facilitate the under-
standing of neurodegenerative pathways in AD. They remain an
invaluable tool for identifying molecular, cellular and pathological
changes that trigger the onset of cognitive decline in AD. Further-
more, models should allow for the testing of compounds at various
points of the pathogenetic cascade in order to search for disease
modifying drugs. Here we propose the sea urchin P. lividus as an
effective and simple model organism for studies of development
and disease processes. Moreover, sea urchin occupies a key phylo-
genetic position as the only nonchordate detereustomes and the
results obtained on this embryo can be extrapolated and compared
to those of higher eukaryotes such as mammalian.
Here, we have used the sea urchin embryo to investigate about
the degenerative pathway activated after a separate treatment
with oligomers and fibrillar aggregates of a recombinant amyloid
peptide. Employment of a recombinant Ab peptide, with or without
amino acids mutation, is an experimental approach that has been
already employed to correlate structure and biological activity
[22].
At the beginning to validate sea urchin as a model system for
investigating about molecular mechanisms activated in AD, we
ascertain the presence of a PlAPP-related antigen. This antigen is
Fig. 5. Oligomers and fibrillar aggregates activate different caspases. P. lividus
embryos at gastrula stage were treated with aggregates, oligomers or a caspase
activator, without and with z-VAD-fmk and submitted to caspase 8 (A) or 9 (B) or 3
(C) luminescent assays. Inhibition of caspase 8 (A) and 9 (B) or 3 (C) activation was
observed after incubation of P. lividus embryos with oligomers or aggregates or
caspase activator plus z-VAD-fmk. As controls untreated embryos were utilized. On
the left value expressed as a percentage of controls. The blank control values were
subtracted from each. The data are means ± SD of three separate experiments,
normalized respect to the control.
Fig. 6. z-VAD-fmk caspase inhibitor is able to rescue rAb42 oligomers treated
P. lividus. (A) untreated embryos (control) or treated with rAb42 oligomers or with
z-VAD-fmk together rAb42 oligomers.
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processed by gastrula stage, indicating that the production of a
polypeptide is a conserved event for which, perhaps, presence of
specific secretase is required. Similarly, a fragment of about
10 kDa is produced by a-secretase proteolitic cleavage of human
APP, an alternative mechanism to Ab formation that gives origin
to the so called non-amyloidogenic pathway [4,23,24]. It will be
interesting, in future, to investigate about the presence of secreta-
ses in sea urchin embryos, in particular of a-, b- and c-secretase,
the enzymes involved in human APP processing [23,24].
The presence of a PlAPP-like antigen, together with the localiza-
tion of the rAb42 in P. lividus primordial nervous system, is an
encouraging data for our proposed aim, i.e., to utilize sea urchin
to test cellular answer to Ab treatment. It has been, indeed, re-
ported that Ab aggregates interact with their same precursor and
this leads to a toxic gain of function, possibly by inducing an APP
conformational change that triggers to cell death [24,25].
Neurodegeneration has been often associated to the pro-
grammed cell death mechanism, well known as apoptosis. Some
studies have demonstrated an involvement of Ab42 aggregates in
activation of apoptosis and recent evidence have indicated that sol-
uble protofibrils and small oligomers have toxic properties [26].
Thus, the toxicity is independent by the complexity of the aggre-
gates, but perhaps differs by activating different intracellular or
extracellular pathway, some of which can cross-talks among them,
and induce degeneration.
Apoptosis in sea urchin development was investigated both for
physiological events and for exposure to cytotoxic chemicals, heat
stress, metals [21,27–29] or in response to UV radiation [30]. Here,
we demonstrate that exposure to rAb42 oligomers and fibrillar
aggregates induces cell death by apoptosis and this event is med-
iated by caspases and reverted by a caspase inhibitor. Moreover,
we demonstrated that aggregates employ exclusively extrinsic
pathway, whereas oligomers both extrinsic and intrinsic pathways.
This data suggests that a part of smaller soluble oligomers are able
to penetrate into the cells and produce mitochondrial damage that
activates caspase 9. Another part of oligomers could attach on neu-
ron surface specific binding site and, perhaps, seed the aggregation
process miming what in human pathology occurs. Moreover, the
evidence that oligomers produce cell death by two apoptotic path-
ways could justify why, as previously demonstrated, oligomers re-
sult more toxic than aggregates [16]. Some evidences indicate that
a mechanism of Ab toxicity arises from its interaction with mito-
chondrial target such as Ab-binding alcohol dehydrogenase (ABAD)
[31–33]. Nevertheless, the possibility that small oligomers cross
the membrane and penetrate into the intracellular environment
could be in agreement with biophysical and modelling studies that
have demonstrated the ability of Ab to interact with a lipid bilayer
due to its obliquity and hydrophobicity [34]. Moreover, some evi-
dence indicates that extracellular Ab contribute to the intracellular
pool of Ab, and this internalization occurs via an endocytic path-
way involving caveolae/lipid rafts [35]. However, we cannot ex-
clude that small oligomers, penetrating into the cells, produce
stress to other intracellular organelles, such as endoplasmic retic-
ulum. Identification of specific intracellular target for Ab42 can
be relevant to design therapeutic interventions aimed at prevent-
ing the neurotoxicity associated with b-amyloid protein.
Moreover, cell death signalling can start by the cell surface and
we cannot exclude that especially rAb42 aggregates, as well as
neuritic plaques, trigger toxicity via membrane proteins. Recent re-
ports indicate that monomeric and fibrillar forms of Ab have the
ability to bind to different membrane proteins and some of them
have been identified [36,37]. As suggested, Ab aggregates act as a
membrane perturbant which alter the lipid bilayer and mem-
brane-bound proteins or receptors, inducing activation of cell
death pathway [38]. Thus, depending on the aggregation state,
Ab induced toxicity could occur through different paths and a sim-
ple model system can help, in future, to identify some of them. Fur-
ther, in embryos exposed to z-VAD-fmk caspase activity was
inhibited, indicating that P. lividus can provide a model to test
the effectiveness of different compounds in offsetting the damage
caused by Ab42.
Finally, as transgenesis in Drosophila, Caenorhabditis elegans and
zebrafish [39–43] have opened new possibilities in the screening of
protein partners, modified genes and potential therapeutic mole-
cules against AD, on the basis of the reported results, we retain that
sea urchin can also be a good candidate for this kind of studies.
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